Albion Financial Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109 | Hold |
200
| – | – | ﹤0.01% | 571 |
|
|
2025
Q1 | $132 | Hold |
200
| – | – | ﹤0.01% | 588 |
|
|
2024
Q4 | $204 | Hold |
200
| – | – | ﹤0.01% | 661 |
|
|
2024
Q3 | $174 | Hold |
200
| – | – | ﹤0.01% | 493 |
|
|
2024
Q2 | $72 | Hold |
200
| – | – | ﹤0.01% | 502 |
|
|
2024
Q1 | $135 | Hold |
200
| – | – | ﹤0.01% | 486 |
|
|
2023
Q4 | $109 | Hold |
200
| – | – | ﹤0.01% | 467 |
|
|
2023
Q3 | $120 | Hold |
200
| – | – | ﹤0.01% | 465 |
|
|
2023
Q2 | $260 | Hold |
200
| – | – | ﹤0.01% | 452 |
|
|
2023
Q1 | $352 | Hold |
200
| – | – | ﹤0.01% | 424 |
|
|
2022
Q4 | $628 | Hold |
200
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 427 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 508 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 573 |
|
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 544 |
|
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 467 |
|
|
2021
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 463 |
|
|
2020
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 411 |
|